Middle-age Asian male with cerebral venous thrombosis after COVID-19 AstraZeneca vaccination
CY Guan, SH Tsai, JS Fan, YK Lin, CC Kao - The American Journal of …, 2022 - Elsevier
Vaccine-associated cerebral venous thrombosis has become an issue following the
extensive vaccination program of the Coronavirus Disease of 2019 (COVID-19) Vaccine
AstraZeneca (ChAdOx1 vaccine). The importance of early diagnosis should be emphasized
due to the high mortality rate without appropriate treatment. Young female populations in
western countries have been reported to be at a greater risk of this vaccine related
thrombotic event, but cases in East Asia are lacking. Herein, we present the first case of …
extensive vaccination program of the Coronavirus Disease of 2019 (COVID-19) Vaccine
AstraZeneca (ChAdOx1 vaccine). The importance of early diagnosis should be emphasized
due to the high mortality rate without appropriate treatment. Young female populations in
western countries have been reported to be at a greater risk of this vaccine related
thrombotic event, but cases in East Asia are lacking. Herein, we present the first case of …